Epidemiological evolution of COVID-19 in Brazil and worldwide
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
DOI: | 10.33448/rsd-v9i7.4653 |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/4653 |
Resumo: | Objective: to analyze the epidemiological evolution of COVID-19 in Brazil correlating to the current world scenario. Methodology: this is an analytical and documentary epidemiological study with a quantitative and descriptive approach of secondary data from COVID-19 of the Special Epidemiological Bulletin number 15 of the Ministry of Health of Brazil on the epidemiological situation until May 8, 2020. Results: the United States leads in number of confirmed cases 1,318,787 (33%) and deaths 78,503 (28%) in the world. Brazil, occupies the 8th place with 145,328 (4%) of the confirmed cases of COVID-19, its lethality is 6.8% and mortality is 46.6 per 1,000,000 inhabitants. In 2020, 107,895 hospitalizations for Severe Acute Respiratory Syndrome were registered in Brazil, of which 27,086 (25%) were confirmed cases of COVID-19 and 7,514 (28%) died, with people aged 60 or over 5,697 (69%) of the cases and heart diseases and diabetes were the risk groups that stood out considerably in the deaths of the elderly. Conclusion: the disease is not yet under control, social distance and the use of masks are the best way to prevent the progression of cases and deaths by COVID-19. |
id |
UNIFEI_5bd7b9e995df85e23cf44a43e877d9c7 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/4653 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
spelling |
Epidemiological evolution of COVID-19 in Brazil and worldwideEvolución epidemiológica de COVID-19 en Brasil y en todo el mundoEvolução epidemiológica da COVID-19 no Brasil e no mundoCoronavírusPandemiaEpidemiologiaMortalidade.CoronavirusPandemiaEpidemiologíaMortalidad.CoronavirusPandemicEpidemiologyMortality.Objective: to analyze the epidemiological evolution of COVID-19 in Brazil correlating to the current world scenario. Methodology: this is an analytical and documentary epidemiological study with a quantitative and descriptive approach of secondary data from COVID-19 of the Special Epidemiological Bulletin number 15 of the Ministry of Health of Brazil on the epidemiological situation until May 8, 2020. Results: the United States leads in number of confirmed cases 1,318,787 (33%) and deaths 78,503 (28%) in the world. Brazil, occupies the 8th place with 145,328 (4%) of the confirmed cases of COVID-19, its lethality is 6.8% and mortality is 46.6 per 1,000,000 inhabitants. In 2020, 107,895 hospitalizations for Severe Acute Respiratory Syndrome were registered in Brazil, of which 27,086 (25%) were confirmed cases of COVID-19 and 7,514 (28%) died, with people aged 60 or over 5,697 (69%) of the cases and heart diseases and diabetes were the risk groups that stood out considerably in the deaths of the elderly. Conclusion: the disease is not yet under control, social distance and the use of masks are the best way to prevent the progression of cases and deaths by COVID-19.Objetivo: analizar la evolución epidemiológica de COVID-19 en Brasil en correlación con el escenario mundial actual. Metodología: este es un estudio epidemiológico analítico y documental con un enfoque cuantitativo y descriptivo de datos secundarios del COVID-19 del Boletín Epidemiológico Especial número 15 del Ministerio de Salud de Brasil sobre la situación epidemiológica hasta el 8 de mayo de 2020. Resultados: Estados Unidos lidera en número de casos confirmados 1.318.787 (33%) y muertes 78.503 (28%) en el mundo. Brasil, ocupa el octavo lugar con 145,328 (4%) de los casos confirmados de COVID-19, su letalidad es de 6.8% y la mortalidad es de 46.6 por 1,000,000 de habitantes. En 2020, se registraron 107.895 hospitalizaciones por síndrome respiratorio agudo severo en Brasil, de las cuales 27.086 (25%) fueron casos confirmados de COVID-19 y 7.514 (28%) murieron, con personas de 60 años o más 5.697 (69%) de los casos y enfermedades cardíacas y diabetes fueron los grupos de riesgo que se destacaron considerablemente en las muertes de ancianos. Conclusión: la enfermedad aún no está bajo control, la distancia social y el uso de máscaras son la mejor manera de prevenir la progresión de casos y muertes por COVID-19.Objetivo: analisar a evolução epidemiológica da COVID-19 no Brasil correlacionando ao cenário mundial atual. Metodologia: trata-se de um estudo epidemiológico analítico e documental com abordagem quantitativa e descritiva de dados secundários da COVID-19 do Boletim Epidemiológico Especial número 15 do Ministério da Saúde do Brasil sobre a situação epidemiológica até o dia 08 de maio de 2020. Resultados: os Estados Unidos lideram em número de casos confirmados 1.318.787 (33%) e óbitos 78.503 (28%) no mundo. O Brasil, ocupa o 8º lugar com 145.328 (4%) dos casos confirmados de COVID-19, a sua letalidade está em 6,8% e a mortalidade é de 46,6 por 1.000.000 de habitantes. Em 2020, registrou-se 107.895 hospitalizações por Síndrome Respiratória Aguda Grave no Brasil, desse total, 27.086 (25%) eram casos confirmados de COVID-19 e 7.514 (28%) evoluíram para óbito, sendo as pessoas com 60 anos ou mais 5.697 (69%) dos casos e as cardiopatias e o diabetes os grupos de risco que destacaram-se consideravelmente nos óbitos dos idosos. Conclusão: a doença ainda não está sob controle, o distanciamento social e o uso de máscaras são a melhor forma de evitar a progressão de casos e mortes por COVID-19.Research, Society and Development2020-05-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/465310.33448/rsd-v9i7.4653Research, Society and Development; Vol. 9 No. 7; e630974653Research, Society and Development; Vol. 9 Núm. 7; e630974653Research, Society and Development; v. 9 n. 7; e6309746532525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/4653/4022Copyright (c) 2020 Gabriel Mauriz de Moura Rocha, Aldenora Maria Ximenes Rodrigues, Bruno Nascimento Sales, Grasyele Oliveira Sousa, Guilherme Antônio Lopes de Oliveirainfo:eu-repo/semantics/openAccessSousa, Grasyele OliveiraSales, Bruno NascimentoRodrigues, Aldenora Maria XimenesRocha, Gabriel Mauriz de MouraOliveira, Guilherme Antônio Lopes de2020-08-20T18:05:03Zoai:ojs.pkp.sfu.ca:article/4653Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:28:26.086822Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Epidemiological evolution of COVID-19 in Brazil and worldwide Evolución epidemiológica de COVID-19 en Brasil y en todo el mundo Evolução epidemiológica da COVID-19 no Brasil e no mundo |
title |
Epidemiological evolution of COVID-19 in Brazil and worldwide |
spellingShingle |
Epidemiological evolution of COVID-19 in Brazil and worldwide Epidemiological evolution of COVID-19 in Brazil and worldwide Sousa, Grasyele Oliveira Coronavírus Pandemia Epidemiologia Mortalidade. Coronavirus Pandemia Epidemiología Mortalidad. Coronavirus Pandemic Epidemiology Mortality. Sousa, Grasyele Oliveira Coronavírus Pandemia Epidemiologia Mortalidade. Coronavirus Pandemia Epidemiología Mortalidad. Coronavirus Pandemic Epidemiology Mortality. |
title_short |
Epidemiological evolution of COVID-19 in Brazil and worldwide |
title_full |
Epidemiological evolution of COVID-19 in Brazil and worldwide |
title_fullStr |
Epidemiological evolution of COVID-19 in Brazil and worldwide Epidemiological evolution of COVID-19 in Brazil and worldwide |
title_full_unstemmed |
Epidemiological evolution of COVID-19 in Brazil and worldwide Epidemiological evolution of COVID-19 in Brazil and worldwide |
title_sort |
Epidemiological evolution of COVID-19 in Brazil and worldwide |
author |
Sousa, Grasyele Oliveira |
author_facet |
Sousa, Grasyele Oliveira Sousa, Grasyele Oliveira Sales, Bruno Nascimento Rodrigues, Aldenora Maria Ximenes Rocha, Gabriel Mauriz de Moura Oliveira, Guilherme Antônio Lopes de Sales, Bruno Nascimento Rodrigues, Aldenora Maria Ximenes Rocha, Gabriel Mauriz de Moura Oliveira, Guilherme Antônio Lopes de |
author_role |
author |
author2 |
Sales, Bruno Nascimento Rodrigues, Aldenora Maria Ximenes Rocha, Gabriel Mauriz de Moura Oliveira, Guilherme Antônio Lopes de |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Sousa, Grasyele Oliveira Sales, Bruno Nascimento Rodrigues, Aldenora Maria Ximenes Rocha, Gabriel Mauriz de Moura Oliveira, Guilherme Antônio Lopes de |
dc.subject.por.fl_str_mv |
Coronavírus Pandemia Epidemiologia Mortalidade. Coronavirus Pandemia Epidemiología Mortalidad. Coronavirus Pandemic Epidemiology Mortality. |
topic |
Coronavírus Pandemia Epidemiologia Mortalidade. Coronavirus Pandemia Epidemiología Mortalidad. Coronavirus Pandemic Epidemiology Mortality. |
description |
Objective: to analyze the epidemiological evolution of COVID-19 in Brazil correlating to the current world scenario. Methodology: this is an analytical and documentary epidemiological study with a quantitative and descriptive approach of secondary data from COVID-19 of the Special Epidemiological Bulletin number 15 of the Ministry of Health of Brazil on the epidemiological situation until May 8, 2020. Results: the United States leads in number of confirmed cases 1,318,787 (33%) and deaths 78,503 (28%) in the world. Brazil, occupies the 8th place with 145,328 (4%) of the confirmed cases of COVID-19, its lethality is 6.8% and mortality is 46.6 per 1,000,000 inhabitants. In 2020, 107,895 hospitalizations for Severe Acute Respiratory Syndrome were registered in Brazil, of which 27,086 (25%) were confirmed cases of COVID-19 and 7,514 (28%) died, with people aged 60 or over 5,697 (69%) of the cases and heart diseases and diabetes were the risk groups that stood out considerably in the deaths of the elderly. Conclusion: the disease is not yet under control, social distance and the use of masks are the best way to prevent the progression of cases and deaths by COVID-19. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-05-29 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/4653 10.33448/rsd-v9i7.4653 |
url |
https://rsdjournal.org/index.php/rsd/article/view/4653 |
identifier_str_mv |
10.33448/rsd-v9i7.4653 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/4653/4022 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 9 No. 7; e630974653 Research, Society and Development; Vol. 9 Núm. 7; e630974653 Research, Society and Development; v. 9 n. 7; e630974653 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1822178759639302144 |
dc.identifier.doi.none.fl_str_mv |
10.33448/rsd-v9i7.4653 |